Philadelphia, PA, June 25, 2007 – State policies have a significant impact on the services performed by substance abuse treatment programs, and could play a key role in efforts to expand the use of research-based "comprehensive" treatment approaches, reports a study in the June issue of the Journal of Substance Abuse Treatment (JSAT).
"The states are uniquely positioned to institute specific policy proscriptions emanating from scientific research in the substance abuse treatment arena, indicating that a comprehensive approach…[is] associated with positive treatment outcomes and reduced recidivism," according to the researchers, led by Jamie F. Chriqui, Ph.D., M.H.S., of University of Illinois at Chicago.
Dr. Chriqui and colleagues gathered data on state policy requirements regarding outpatient substance abuse treatment programs. They focused on state-authorized programs, which make up the vast majority of drug and alcohol abuse programs in the United States. The study included data on more than 9,000 drug treatment programs nationwide.
Nearly all of the programs were in a state with policies requiring some type of assessment for substance abuse treatment programs. However, most were in states that did not mandate the use of comprehensive diagnostic criteria, such as those published by the American Society for Addiction Medicine.
Most programs were in states requiring some type of group and individual counseling or therapy, but not family counseling or therapy. Studies have found that family counseling is an important part of successful substance abuse treatment. Few programs were in states requiring specific types of medical tests. For example, only six percent of programs were required to perform drug or alcohol testing/screening. Most programs were not in states requiring testing for diseases related to substance abuse, such as hepatitis and sexually transmitted diseases, including HIV. Less than 30 percent of programs were in states requiring relapse-prevention services. Just over 40 percent were required to provide aftercare counseling services.
When the researchers looked at what services the programs actually provided, there was a closer correspondence to research recommendations. Almost all programs performed diagnostic assessment and group and individual therapy, although rates of family counseling were lower. Nearly all programs performed urine screening for drugs and alcohol, but most did not test for substance-abuse related diseases. Most programs did provide relapse-prevention and aftercare services.
When other factors were taken into account, programs in states requiring more comprehensive services were more likely to offer those services. "The results…indicate that state policy requirements governing outpatient substance abuse treatment may have significant public health implications," the researchers write.
In recent years, major federal and other national organizations have urged the states to play a more active role in ensuring access to proven and effective treatments for substance abuse. A growing body of research shows that comprehensive treatment programs, including all of the components evaluated in this study, yield the best outcomes.
State policies could play a central role in improving the quality of substance abuse treatment programs, the new results suggest. Simply doing research on the most effective treatment approaches is not enough—strategies are also needed to ensure that the research-proven approaches find their way into actual treatment practice. "It is crucial for health services researchers to work with policy makers to incorporate best treatment practices into state policy and regulations," Dr. Chriqui and colleagues conclude.
Notes to Editors:
Full text of the articles mentioned above is available upon request. Contact Jayne M. Dawkins at (215) 239-3674 or ja.dawkins@elsevier.com to obtain a copy or to schedule an interview. The articles appear in the Journal of Substance Abuse Treatment, June 2008, published by Elsevier.
About the Journal of Substance Abuse Treatment
The Journal of Substance Abuse Treatment (JSAT) features original reviews, training and educational articles, special commentary, and especially research articles that are meaningful to the treatment of alcohol, heroin, marijuana, and other drugs of dependence. JSAT is directed toward treatment practitioners from all disciplines (medicine, nursing, social work, psychology, and counseling) in both private and public sectors, including those involved in schools, health centers, community agencies, correctional facilities, and individual practices.
About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com/), MD Consult (http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/), bibliographic databases, and online reference works.
Elsevier (http://www.elsevier.com/) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Journal
Journal of Substance Abuse Treatment